Autobio Diagnostics Co., Ltd. Stock
Equities
603658
CNE100002GC4
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 35.97 CNY | +0.67% |
|
+0.84% | -17.58% |
| Nov. 27 | Autobio Diagnostics Gets 18 Medical Device Registrations in Henan | MT |
| Oct. 29 | Autobio Diagnostics Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025 | CI |
| Capitalization | 20.55B 2.92B 2.48B 2.32B 2.17B 4.01B 265B 4.4B 27.09B 10.45B 125B 10.95B 10.72B 452B | P/E ratio 2025 * |
17.3x | P/E ratio 2026 * | 15.3x |
|---|---|---|---|---|---|
| Enterprise value | 20.55B 2.92B 2.48B 2.32B 2.17B 4.01B 265B 4.4B 27.09B 10.45B 125B 10.95B 10.72B 452B | EV / Sales 2025 * |
4.71x | EV / Sales 2026 * | 4.28x |
| Free-Float |
29.86% | Yield 2025 * |
3.45% | Yield 2026 * | 3.83% |
| 1 day | +0.67% | ||
| 1 week | +0.84% | ||
| Current month | -1.64% | ||
| 1 month | -8.54% | ||
| 3 months | -12.35% | ||
| 6 months | -3.49% | ||
| Current year | -17.58% |
| 1 week | 35.14 |  | 36.1 |
| 1 month | 35.14 | | 38.4 |
| Current year | 35.14 | | 45.17 |
| 1 year | 35.14 | | 46.66 |
| 3 years | 35.14 | | 71.85 |
| 5 years | 35.14 | | 121.93 |
| 10 years | 13.46 | | 139.22 |
| Manager | Title | Age | Since |
|---|---|---|---|
Zeng Li Yang
CEO | Chief Executive Officer | 57 | 2018-10-28 |
Chao Jie Feng
DFI | Director of Finance/CFO | 47 | 2012-11-12 |
Wei Liu
ADM | Chief Administrative Officer | 49 | 2005-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Ya Xun Zhang
BRD | Director/Board Member | 60 | 2005-12-31 |
Xue Wei Wu
BRD | Director/Board Member | 58 | 2002-12-31 |
Guang Yu Fu
BRD | Director/Board Member | 56 | 2012-11-12 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 0.56% | 0 M€ | -19.71% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.67% | +0.84% | -20.51% | -39.52% | 2.92B | |
| -0.19% | +2.39% | +5.63% | +11.90% | 14.9B | |
| -2.60% | -3.11% | +180.74% | +232.67% | 12.88B | |
| +3.37% | +1.66% | - | - | 7.79B | |
| +2.03% | -0.17% | -14.05% | +24.92% | 6.61B | |
| -2.10% | +7.05% | -30.28% | +22.96% | 4.32B | |
| 0.00% | +3.04% | -37.34% | -50.76% | 4.01B | |
| +0.75% | +4.12% | -3.70% | -32.84% | 2.49B | |
| -9.30% | -5.70% | +206.29% | +118.67% | 2.17B | |
| -0.32% | -11.94% | +4.80% | -55.87% | 1.99B | |
| Average | -0.77% | -0.33% | +32.40% | +25.79% | 6.01B | |
| Weighted average by Cap. | -0.38% | +0.61% | +46.44% | +60.92% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 4.36B 619M 526M 492M 461M 851M 56.3B 933M 5.75B 2.22B 26.45B 2.32B 2.27B 95.87B | 4.8B 682M 579M 542M 508M 938M 62.03B 1.03B 6.33B 2.44B 29.14B 2.56B 2.51B 106B |
| Net income | 1.17B 166M 141M 132M 123M 228M 15.07B 250M 1.54B 594M 7.08B 622M 609M 25.66B | 1.31B 186M 158M 148M 139M 256M 16.93B 281M 1.73B 667M 7.95B 698M 684M 28.83B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-16 | 35.97 ¥ | +0.67% | 2,365,572 |
| 25-12-15 | 35.73 ¥ | +0.70% | 1,943,561 |
| 25-12-12 | 35.48 ¥ | +0.28% | 2,039,649 |
| 25-12-11 | 35.38 ¥ | -1.01% | 2,323,639 |
| 25-12-10 | 35.74 ¥ | +0.20% | 2,607,243 |
End-of-day quote Shanghai S.E., December 15, 2025
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 603658 Stock
Select your edition
All financial news and data tailored to specific country editions
